Navigation Links
Roadmap to 25 percent reduction in premature deaths From RHD in the under 25s by 2025 published

The World Heart Federation has published a new position statement outlining the five key strategic targets required to meet its strategic goal for rheumatic heart disease (RHD) a 25% reduction in premature deaths from rheumatic fever (RF) and RHD among individuals aged <25 years by the year 2025.

RHD remains the most common cardiovascular disease in young people aged <25 years. RF and RHD have been almost eradicated in areas with establish economies. But RF and RHD are endemic in developing countries and are also common in poorer populations in middle-income countries (e.g. Brazil, India), as well as some indigenous populations in wealthy countries (Australia, New Zealand). Moreover, migration from low-income to high-income settings might be responsible for a new burden of RHD in high-income countries where the disease has been largely eliminated.

Conservative estimates indicate that there are between 15.6 and 19.6 million existing cases of RHD and its been estimated that there are around 252,000 new cases each year. Moreover, an estimated 233,000 to 468,164 individuals die from RHD each year, and hundreds of thousands of people are disabled by this disease and its long-term complications.

"RF and RHD are neglected diseases that require immediate attention," Professor Bongani Mayosi, Groote Schuur Hospital and University of Cape Town, South Africa; and Chair of the World Heart Federation Working Group on Rheumatic Fever and Rheumatic Heart Disease. "This position paper will form the platform for a detailed operational plan to address the barriers to RF and RHD control. The operational plan will be founded on science, research and quantifiable progress indicators to impact positively on millions of individuals with RHD."

A number of barriers have been identified that are currently preventing the control of RF and RHD.

  • Neglect of RF and RHD there is a relative lack of engagement in disease control by governments, civil society, patient advocates and funding agencies.
  • Scarcity of data and scientific knowledge Contemporary data is scarce. The current global figure for RHD mortality is speculative and likely to be a gross underestimate. But, descriptive and prognostic epidemiological data outlining disease prevalence, mortality and morbidity are critical for developing realistic targets and key performance indicators towards disease control.
  • Research Global research priorities for RF and RHD have been identified but there is a great need for resource allocation to conduct robust research into these priorities.
  • Vaccines a GAS vaccine is required for effective population-level primary prevention of RF is needed. GAS vaccine development and human testing has been underway for nearly a century with fluctuating enthusiasm. Few pharmaceutical companies have active internal programmes.
  • Access to health care Barriers exist to optimal primary, secondary and tertiary (medical and surgical care). Many patients around the world do not have access to the treatments they need at all stages of management.

The primary aim of this position paper is to serve as a guide on how to achieve the objective of controlling RHD and eliminating RF. Five strategic targets have been identified:

  1. Comprehensive register-based control programmes
  2. Global access to benzathine penicillin G
  3. Identification and development of public figures as 'RHD champions'
  4. Expansion of RHD training hubs
  5. Support for vaccine development

Moreover, this document is intended to provide the foundation for governments, civil society, patient advocates, clinicians, researchers and funding agencies to develop partnerships and unify global efforts to control RF and RHD.


Contact: Charanjit Jagait
World Heart Federation

Related medicine news :

1. Study provides roadmap for delirium risks, prevention, treatment, prognosis and research
2. Alzheimers experts from Penn Summit provide strategic roadmap to tackle the disease
3. New roadmap suggests proven routes to ending health disparities
4. Ready for debut: Fruit-juice-infused chocolate with 50 percent less fat
5. Nearly 30 Percent of Americans Have High Blood Pressure: CDC
6. CodingCertification.Org in the Top 5 Percent in LinkedIn Most Viewed Profiles in 2012
7. Common gene variants explain 42 percent of antidepressant response
8. Port Washington, NY Dentist Dr. Doron Keren of Gold Coast Family Dental Receives 98 Percent Satisfaction Rating from Patient Reviews
9. Newly incarcerated have 1 percent acute hepatitis C prevalence
10. Sports and recreation injuries drop 12 percent for children ages 5-14 during past decade
11. Telestroke program increases access to stroke care by 40 percent
Post Your Comments:
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: